Mira
Mira (Quanovate Tech Inc.) is a U.S. femtech company selling an FDA-listed, CE-certified at-home hormone monitoring platform using fluorescent immunoassay technology, paired with an AI app trained on 1.7M+ cycles. It sells directly to consumers and through enterprise fertility benefits, serving women trying to conceive, those with PCOS or irregular cycles, and perimenopausal women.
- Company typePrivate
- Founded2015
- HeadquartersPleasanton, United States
- Headcount101–250
- GTM typeB2C
- OfferingHardware or Manufacturing
What Mira does
Mira (legal entity Quanovate Tech Inc.) is a U.S.-based women's hormonal health company founded in 2015 by Sylvia Kang, a biomedical engineer, and co-founder Zheng Yang, headquartered in San Ramon, California. The company sells a proprietary at-home hormone monitoring platform built on fluorescent immunoassay technology, which delivers lab-quality quantitative measurement of multiple reproductive hormones (LH, E3G, PdG, and on the flagship Ultra4 also FSH) via swappable single-use test wands read by a connected monitor device, with results delivered in approximately 16 minutes at claimed 99% accuracy. The system is paired with the Mira mobile application (iOS/Android) and an AI layer trained on a proprietary dataset of more than 1.7 million real cycles and 30 million hormone data points, which produces personalized ovulation prediction, cycle insights, and support for irregular cycles, PCOS, and perimenopause.
The business operates a razor/blade model: a one-time hardware purchase (Ultra4 Kit at $249, plus Max and Basic kit tiers) anchors the customer, and recurring revenue comes from consumable wand packs (e.g., $99 for 20 Ultra4 Wands, with active cyclers using 10-20 wands per cycle), auto-renew subscriptions, supplements, at-home lab tests, and 1:1 certified hormone health consultations. Distribution is primarily direct-to-consumer through an owned Shopify storefront with warehouses in the USA, UK, France, Netherlands, China, and Australia shipping to 115 countries, supplemented by the Carrot Collective enterprise marketplace, a corporate benefits sales motion (e.g., Twic), and a healthcare-professional referral network of 3,000+ providers and 50+ university/clinic research partnerships. The product portfolio has been extended beyond core fertility tracking into the Menopause Transitions Kit (October 2024), an integrative hormone health clinic (July 2024), and an Oura Ring integration (February 2026). The company is FDA-listed and CE-certified, was named America's fastest-growing femtech in 2023 with 1,323% three-year revenue growth, and has cumulatively reported 30,000 pregnancies among its 250,000+ users.
Mira firmographics
Firmographics- Name
- Mira
- Legal name
- Quanovate Tech Inc.
- Website
- https://miracare.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Mira (Quanovate Tech Inc.) is a U.S. femtech company selling an FDA-listed, CE-certified at-home hormone monitoring platform using fluorescent immunoassay technology, paired with an AI app trained on 1.7M+ cycles. It sells directly to consumers and through enterprise fertility benefits, serving women trying to conceive, those with PCOS or irregular cycles, and perimenopausal women.
- Ownership category
- akta.pro rank
Mira industry classification
Industry- Product category
- At-Home Hormone Monitoring Devices
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical and Diagnostic Laboratories (62151)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)
- akta.pro secondary industries
- Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK), Women’s Health & Fertility Tracking Devices (Ovulation/Temp Sensors, Pelvic Health Devices) (CRACAQAJ), Maternal & High-Risk Pregnancy Remote Monitoring (BP, glucose, fetal/uterine monitoring) (HLALAFAG), Fertility & Ovulation Products (OTC) (CRABAIAK), Women’s Health & Fertility Therapeutics (Digital) (HLACANAK)
Keywords
Where Mira is headquartered
LocationHeadquarters
- HQ city
- Pleasanton
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
Mira business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Marketing or Sales, Operations, Personnel
Revenue model
- Hardware Sales - Hormone Monitors: One-time purchase of hormone monitoring devices (Ultra4 Kit at $249). Includes monitor and wands. Device provides lab-quality hormone testing using fluorescent immunoassay technology.
- Consumables - Hormone Test Wands: Recurring consumable revenue from test wands. Multiple wand types available (Ultra4 Wands, Max Wands, Plus Wands, Ovum Wands, Confirm Wands). Typically 10-20 wands needed per cycle for consistent tracking.
- Subscription Services: Subscription model for recurring orders with automatic renewal. Subscribers receive scheduled wand deliveries with potential discounts. Financing options available for kit purchases.
- Expert Consultations: 1:1 virtual consultations with certified hormone health coaches for fertility support and menopause guidance. Part of integrative hormone health clinic services.
- Supplements: Fertility support supplements including Prenatal Multi-Vitamins, PCOS Supplements, and Fertility Tea for complementary revenue.
- Lab Tests: Panorama Fertility Lab Test - at-home blood test for 5 key hormones. Male Fertility Kit for sperm analysis.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Ultra4 Kit - Core hormone monitoring system |
| Unit Pricing | Pay-as-you-go | Ultra4 Wands - Replacement test wands |
| Unit Pricing | Pay-as-you-go | Max Kit - Fertility tracking kit |
| Unit Pricing | Pay-as-you-go | Basic Kit - Entry-level fertility tracking |
| Subscription | Monthly | Subscription Services |
| Subscription | Monthly | 1:1 Expert Consultations |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
Mira product offering
Product offeringCore offering
Mira sells FDA-listed and CE-certified at-home hormone monitoring hardware kits (Ultra4, Max, Basic) paired with swappable test wands that quantify fertility hormones (LH, E3G, PdG, FSH) using fluorescent immunoassay technology. The offering is completed by a companion AI-powered mobile app for personalized cycle insights, recurring wand subscriptions, supplements, at-home lab tests, male fertility tests, and 1:1 certified hormone health consultations for fertility and menopause support.
Product overview
Mira is a women's hormonal health company offering a comprehensive at-home hormone monitoring ecosystem. The core product portfolio centers on the Mira Hormone Monitor hardware platform with swappable test wands (Ultra4, Max, Plus, Ovum, and Confirm) that measure various hormone combinations (LH, E3G, PdG, FSH). The system includes companion kits for fertility (Ultra4 Kit, Max Kit, Basic Kit), perimenopause management (Ultra4 Kit for Perimenopause), and male fertility testing. The Mira App serves as the central platform, providing AI-powered cycle analysis, personalized fertility predictions, and biometric data integration. The company also offers supplements (Prenatal Multi-Vitamins, PCOS Supplements, Fertility Tea), clinical consultations (1:1 Certified Fertility Support, 1:1 Certified Menopause Support), at-home lab tests (Panorama Fertility Lab Test), and bundled offerings for couples and pregnancy planning.
Differentiator
Problem solved
Functional benefit
Products and services
- Ultra4 Kit All-in-one at-home hormone monitoring kit that uses 4-in-1 multi-hormone testing to measure LH, E3G, PdG, and FSH in 16 minutes with 99% lab-quality accuracy; intended for women tracking fertility, PCOS, or perimenopause.
- Ultra4 Kit for Perimenopause Hormone monitoring kit built on the Ultra4 platform with a dedicated Menopause Mode for tracking hormonal fluctuations during perimenopause; targets women navigating the menopause transition.
- Max Kit
Quantifiable outcome
- 84% of women got pregnant within their first 6 cycles of using Mira
- +3 more outcomes
Companies that use Mira
Customer profileNamed customers1 record
Segments6 records
Ideal customer profiles4 records
Mira technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability2 records
Feature4 records
Mira partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- FLO LivingcoreClinical study collaboration demonstrating that Cycle Syncing Method significantly reduces PMS symptoms. Study conducted with FLO Living, Mira, Hello Inside, and Citruslabs involving 60 women over three months.
- Hello InsideminorCo-development partner in clinical study on Cycle Syncing Method for PMS symptom reduction.
- CitruslabsminorClinical research partner conducting study on Cycle Syncing Method with Mira and other femtech companies.
- ŌURAcoreDirect integration allowing Mira users to view Oura Ring's sleep, readiness, and temperature trends alongside their hormone data within the Mira app. Enables correlation of hormonal fluctuations with daily biometric signals across fertility, perimenopause, and hormonal imbalance use cases.
- CarrotcoreMira products featured in Carrot Collective marketplace offering clinically vetted fertility and hormonal health products to Carrot members globally at no additional cost to employers.
- FLO LivingcoreFLO Living won Mira's inaugural Hormone Innovators Award for Cycle Syncing Method, recognizing pioneers in hormonal and reproductive health to commemorate the 120th anniversary of hormone discovery.
- Ali RileyminorPartnership with professional soccer star Ali Riley to promote women's hormonal health. Riley shares her personal IVF journey using Mira's hormone tracking technology for empowerment and awareness.
Scale indicators11 records
Recent moves6 records
Expansion highlights7 records
Mira competitors and assessment
Company assessmentDirect peers
- Flo Health: Flo Health operates the Flo app, a leading women's health and period tracker with AI-driven predictions. It competes with Mira on consumer cycle-tracking mindshare and has expanded into insights and premium subscriptions.
- Clue: Clue is one of the most widely used period and ovulation tracking apps globally. It overlaps with Mira's cycle-prediction and consumer-women's-health segments and is also a fellow partner in Oura's women's health ecosystem.
- Natural Cycles: Natural Cycles is an FDA-cleared digital fertility tracking app that uses basal body temperature to identify the fertile window. It directly competes with Mira on hormone-based, app-driven conception and contraception use cases for the same target consumer.
- Premom: Premom offers app-based ovulation prediction paired with affordable LH test strips and quantitative readers. It competes with Mira on the lower-priced ovulation-tracking end and shares an app-driven, hormone-data approach.
- Tempdrop: Tempdrop is a wearable basal body temperature sensor for fertility tracking. It overlaps with Mira on automated, sensor-based temperature and cycle tracking, particularly for women with irregular cycles or shift-based sleep patterns.
- Ava: Ava is a fertility tracking bracelet that combines physiological sensors with cycle prediction software. It competes directly with Mira in the wearables-meets-hormone-tracking category for women trying to conceive.
- Modern Fertility (Ro): Modern Fertility (acquired by Ro) offers at-home hormone testing kits and a digital platform targeting the same women's reproductive health and fertility planning segments as Mira, with strong consumer brand presence in the U.S.
Emerging players
- Elvie: Elvie develops connected women's health hardware (pelvic floor trainers, breast pumps) for the same premium, design-conscious consumer demographic as Mira and is expanding into broader femtech health monitoring.
- Oura: Oura is Mira's biometric integration partner but also a competitive wearable for women's health insights (temperature trends, cycle insights). Overlap exists in cycle-pattern tracking and premium consumer health positioning.
Broad incumbents
- Clearblue (Swiss Precision Diagnostics): Clearblue is the incumbent consumer ovulation and pregnancy test brand, offering colorimetric OPKs and digital monitors. It competes with Mira in at-home ovulation testing and benefits from broad retail distribution and brand recognition.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Mira social profiles
Digital presenceMira compliance and trust
Trust signalCompliance5 records
Mira financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mira leadership team
Management profileNumber of profiles
Profiles2 records
Mira funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mira M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mira
What does Mira do?
Mira sells FDA-listed and CE-certified at-home hormone monitoring hardware kits (Ultra4, Max, Basic) paired with swappable test wands that quantify fertility hormones (LH, E3G, PdG, FSH) using fluorescent immunoassay technology. The offering is completed by a companion AI-powered mobile app for personalized cycle insights, recurring wand subscriptions, supplements, at-home lab tests, male fertility tests, and 1:1 certified hormone health consultations for fertility and menopause support.
Is Mira a public or private company?
Mira is a private company. It is classified as venture growth investor backed and is currently operating.
When was Mira founded?
Mira was founded in 2015. It employs 101 to 250 people.
Where is Mira based?
Mira is headquartered in Pleasanton, United States, in the North America region.
How does Mira make money?
Six revenue lines are on record. Hardware Sales - Hormone Monitors are the primary driver. The others are consumables - Hormone Test Wands, subscription Services, expert Consultations, supplements and lab Tests.
Who are Mira's main competitors?
Direct peers on record are Flo Health, Clue, Natural Cycles, Premom, Tempdrop, Ava and Modern Fertility (Ro). Emerging players are Elvie and Oura. Clearblue (Swiss Precision Diagnostics) is listed as a broad incumbent.
Does Mira have an API?
No public API is recorded for Mira.
What industry is Mira in?
Mira's product category is At-Home Hormone Monitoring Devices. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers), with a secondary code of HLAHAOAK, Home-Use & OTC Rapid Self-Tests (Consumer POCT kits). Its NAICS code is 325413 and its SIC code is 2835.